Previous Article | Next Article ![]()
Mol. Cell. Biol., 06 1995, 3049-3057, Vol 15, No. 6
LM Karnitz, LA Burns, SL Sutor, J Blenis and RT Abraham
Phosphatidylinositol 3-kinase (PI3-K) has been implicated as a signal-
transducing component in interleukin-2 (IL-2)-induced mitogenesis. However,
the function of this lipid kinase in regulating IL-2-triggered downstream
events has remained obscure. Using the potent and specific PI3-K inhibitor,
wortmannin, we assessed the role of PI3-K in IL-2- mediated signaling and
proliferation in the murine T-cell line CTLL-2. Addition of the drug to
exponentially growing cells resulted in an accumulation of cells in the
G0/G1 phase of the cell cycle. Furthermore, wortmannin also partially
suppressed IL-2-induced S-phase entry in G1-synchronized cells. Analysis of
IL-2-triggered signaling pathways revealed that wortmannin pretreatment
resulted in complete inhibition of IL-2-provoked p70 S6 kinase activation
and also attenuated IL-2-induced MAP kinase activation at drug
concentrations identical to those required for inhibition of PI3-K
catalytic activity. Wortmannin also diminished the IL-2-triggered
activation of the MAP kinase activator, MEK, but did not inhibit activation
of Raf, the canonical upstream activator of MEK. These results suggest that
a novel wortmannin-sensitive activation pathway regulates MEK and MAP
kinase in IL-2-stimulated T lymphocytes.
Copyright © 1995, American Society for Microbiology
Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway
Department of Immunology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»